ライフサイエンスコーパス: institutional review board

1 is HIPAA-compliant study was approved by the institutional review board.

2 This retrospective study was approved by the institutional review board.

3 ctive case-control study was approved by the institutional review board.

4 s This prospective study was approved by the institutional review board.

5 ere compliant with HIPAA and approved by the institutional review board.

6 nd HIPAA-compliant study was approved by the institutional review board.

7 tudy was HIPAA compliant and approved by the institutional review board.

8 study and meta-analysis was approved by the institutional review board.

9 iant retrospective study was approved by the institutional review board.

10 This study was approved by the institutional review board.

11 ls and Methods The study was approved by the institutional review board.

12 comparative study was approved by the local institutional review board.

13 This retrospective study was approved by the institutional review board.

14 the protocol was approved by the university institutional review board.

15 was compliant with HIPAA and approved by the institutional review board.

16 a over a 12-month period and approved by the institutional review board.

17 is HIPAA-compliant study was approved by the institutional review board.

18 This retrospective study was approved by the institutional review board.

19 tional animal care and use committee and the institutional review board.

20 s and Methods This study was approved by the institutional review board.

21 ed by the local animal studies committee and institutional review board.

22 ve HIPAA-compliant study was approved by the institutional review board.

23 r, HIPAA-compliant study was approved by the institutional review board.

24 aining written consent under approval of the institutional review board.

25 nter retrospective study was approved by the institutional review board.

26 After approval by the institutional review board, 1,022 LNs in the PET/CT exam

27 s and Methods This study was approved by the institutional review board and all participants gave inf

28 This study was approved by the institutional review board and by national government au

29 s and Methods This study was approved by the institutional review board and compliant with HIPAA and

30 ter, retrospective study was approved by the institutional review board and compliant with HIPAA.

31 This retrospective study was approved by the institutional review board and compliant with HIPAA.

32 This retrospective study was approved by the institutional review board and compliant with HIPAA.

33 This prospective study was approved by the institutional review board and compliant with HIPAA.

34 This study was approved by the institutional review board and compliant with HIPAA.

35 s and Methods This study was approved by the institutional review board and compliant with HIPAA.

36 s All experiments were approved by the local institutional review board and compliant with HIPAA.

37 is cross-sectional study was approved by the institutional review board and compliant with HIPAA.

38 s and Methods This study was approved by the institutional review board and complied with HIPAA.

39 esign and implementation were overseen by an institutional review board and conformed to HIPAA guidel

40 Materials and Methods Institutional review board and informed consent were wai

41 Walter Reed National Military Medical Center institutional review board and is compliant with HIPAA g

42 Walter Reed National Military Medical Center institutional review board and is compliant with HIPAA g

43 Materials and Methods Institutional review board and local ethics committee ap

44 ls and Methods The study was approved by the institutional review board and local ethics committee.

45 s The study was compliant with HIPAA and the institutional review board and required written consent

46 rk with human stem cells was approved by the institutional review board and the stem cell research ov

47 ngle-center cohort study was approved by the institutional review board and was compliant with HIPAA.

48 is was a retrospective study approved by the institutional review board and was HIPAA compliant with

49 ls and Methods The study was approved by the institutional review board and written informed consent

50 s This prospective study was approved by the institutional review boards and compliant with HIPAA.

51 a sharing, establishing common protocols for institutional review boards and data sharing, creating p

52 thods The study protocol was approved by the institutional review boards and was HIPAA compliant.

53 The study was approved by the institutional review board, and all participants gave in

54 s and Methods This study was approved by the institutional review board, and all participants gave wr

55 s and Methods This study was approved by the institutional review board, and all subjects gave signed

56 prospective study was approved by the local institutional review board, and informed consent was obt

57 This retrospective study was approved by the institutional review board, and informed consent was wai

58 nter retrospective study was approved by the institutional review board, and the requirement for info

59 iant retrospective study was approved by the institutional review board, and the requirement for info

60 This retrospective study was approved by the institutional review board, and the requirement to obtai

61 iant retrospective study was approved by the institutional review board, and the requirement to obtai

62 This retrospective study was approved by the institutional review board, and written informed consent

63 s and Methods This study was approved by the institutional review board, and written informed consent

64 ve cross-sectional study was approved by the institutional review boards, and all participants gave i

65 pliant prospective study was approved by the institutional review boards, and written informed consen

66 Materials and Methods This is an institutional review board- and U.S. Food and Drug Admin

67 Materials and Methods The study received institutional review board approval and all patients gav

68 and Methods This prospective study received institutional review board approval and fully complied w

69 Materials and Methods With institutional review board approval and Health Insurance

70 After institutional review board approval and informed consent

71 Materials and Methods Institutional review board approval and informed consent

72 Materials and Methods Institutional review board approval and informed consent

73 Materials and Methods Following institutional review board approval and informed consent

74 Materials and Methods This study had institutional review board approval and was HIPAA compli

75 Materials and Methods Institutional review board approval and written informed

76 Materials and Methods Institutional review board approval and written informed

77 Materials and Methods Institutional review board approval and written informed

78 Materials and Methods Institutional review board approval and written informed

79 Institutional review board approval and written informed

80 Institutional review board approval and written informed

81 Materials and Methods Institutional review board approval and written informed

82 prospective study was HIPAA compliant, with institutional review board approval and written informed

83 ion for colorectal liver metastases, whereas institutional review board approval is required before g

84 Materials and Methods In accordance with the institutional review board approval obtained at the two

85 meet investigational new drug submission and institutional review board approval standards.

86 Materials and Methods Institutional review board approval was given and patien

87 patient information was accessed; therefore, institutional review board approval was not sought.

88 Institutional review board approval was obtained and inf

89 Materials and Methods Institutional review board approval was obtained and inf

90 Materials and Methods Institutional review board approval was obtained and the

91 Materials and Methods Institutional review board approval was obtained for act

92 Materials and Methods Institutional review board approval was obtained for thi

93 Materials and Methods Institutional review board approval was obtained for thi

94 Materials and Methods Institutional review board approval was obtained for thi

95 Materials and Methods Institutional review board approval was obtained for thi

96 Materials and Methods Institutional review board approval was obtained for thi

97 Materials and Methods Institutional review board approval was obtained for thi

98 Materials and Methods Institutional review board approval was obtained for thi

99 Materials and Methods Institutional review board approval was obtained from Le

100 Materials and Methods Institutional review board approval was obtained with wa

101 Materials and Methods Institutional review board approval was obtained, and in

102 Institutional review board approval was obtained, and in

103 Materials and Methods Institutional review board approval was obtained, and in

104 Materials and Methods Institutional review board approval was obtained, and pa

105 Materials and Methods Institutional review board approval was obtained, and th

106 Institutional review board approval was obtained, with w

107 Materials and Methods Institutional review board approval was obtained, with w

108 Materials and Methods Institutional review board approval was obtained.

109 Materials and Methods Institutional review board approval was obtained.

110 Institutional review board approval was obtained.

111 rmed with a waiver of informed consent after institutional review board approval was obtained.

112 sement program in U.S. Materials and Methods Institutional review board approval was waived, as the s

113 HISTORY: Materials and Methods Institutional review board approval was waived, as the s

114 After institutional review board approval with a waiver of inf

115 Materials and Methods This study received institutional review board approval with waiver of conse

116 ective multicenter HIPAA-compliant study had institutional review board approval, and all participant

117 Materials and Methods This study had institutional review board approval, and informed consen

118 This HIPAA-compliant study had institutional review board approval, and informed consen

119 Materials and Methods This study received institutional review board approval, and patients gave i

120 Materials and Methods The study received institutional review board approval, and patients in the

121 s and Methods This HIPAA-compliant study had institutional review board approval, and the need for in

122 als and Methods This retrospective study had institutional review board approval, and the need to obt

123 thods After obtaining antemortem consent and institutional review board approval, the authors compare

124 With institutional review board approval, we searched our pro

125 Materials and Methods Institutional review board approval, with a waiver of in

126 nd Methods This retrospective study received institutional review board approval, with a waiver of th

127 Materials and Methods Following institutional review board approval, with waiver of cons

128 n's prospective database were evaluated with institutional review board approval.

129 iant retrospective study was completed after institutional review board approval.

130 healthy volunteers with informed consent and institutional review board approval.

131 adiation risk and is, therefore, exempt from institutional review board approval.

132 ch, in compliance with HIPAA regulations and institutional review board approval.

133 s This cross-sectional study was exempt from institutional review board approval.

134 als and Methods This retrospective study had institutional review board approval; written informed co

135 Materials and Methods This study was institutional review board approved and HIPAA compliant.

136 This study was institutional review board approved and HIPAA compliant.

137 This retrospective study was institutional review board approved and HIPAA compliant;

138 Each institutional review board approved the prospective stud

139 The institutional review board approved the study and all pa

140 The local institutional review board approved the study, and all p

141 Materials and Methods The institutional review board approved the study.

142 Materials and Methods The institutional review board approved this cross-sectional

143 Materials and Methods The local institutional review board approved this HIPAA-compliant

144 Materials and Methods The institutional review board approved this prospective Hea

145 Materials and Methods The institutional review board approved this prospective hyp

146 The institutional review board approved this prospective stu

147 Materials and Methods The institutional review board approved this prospective, HI

148 The institutional review board approved this retrospective c

149 Materials and Methods The institutional review board approved this retrospective c

150 Materials and Methods The institutional review board approved this retrospective H

151 Materials and Methods An institutional review board approved this retrospective s

152 Materials and Methods The institutional review board approved this retrospective s

153 Materials and Methods Institutional review board approved this retrospective s

154 Materials and Methods The institutional review board approved this retrospective s

155 The institutional review board approved this retrospective s

156 Materials and Methods The institutional review board approved this retrospective s

157 The institutional review board approved this single-institut

158 The institutional review board approved this study and waive

159 Materials and Methods The institutional review board approved this study.

160 Materials and Methods The institutional review board approved use of anonymized CT

161 This study was retrospective, institutional review board approved, and HIPAA compliant

162 This retrospective study was Institutional Review Board approved, and informed consen

163 Materials and Methods This institutional review board approved, HIPAA-compliant ret

164 s This HIPAA-compliant prospective study was institutional review board approved.

165 This retrospective study was institutional review board approved.

166 This study was institutional review board approved; the need for signed

167 Materials and Methods The respective institutional review boards approved this HIPAA-complian

168 Materials and Methods The relevant institutional review boards approved this HIPAA-complian

169 The applicable institutional review boards approved this study, and all

170 rials and Methods This prospective study was institutional review board- approved and HIPAA compliant

171 In this institutional review board-approved and Health Insurance

172 Materials and Methods In this institutional review board-approved and HIPAA-compliant

173 Materials and Methods This was an institutional review board-approved and HIPAA-compliant

174 th 67 CLMs were enrolled in this prospective institutional review board-approved and HIPAA-compliant

175 Materials and Methods This institutional review board-approved and HIPAA-compliant

176 Materials and Methods This was an institutional review board-approved and HIPAA-compliant

177 a prospective, multicenter, HIPAA-compliant, institutional review board-approved clinical trial was p

178 astinal lymph node resection (MLNR) under an Institutional Review Board-approved common protocol from

179 Methods From July 2012 to October 2013, this institutional review board-approved HIPAA-compliant pros

180 Materials and Methods For this institutional review board-approved HIPAA-compliant retr

181 Materials and Methods In this institutional review board-approved HIPAA-compliant retr

182 Materials and Methods This institutional review board-approved HIPAA-compliant retr

183 Materials and Methods In this institutional review board-approved HIPAA-compliant retr

184 Materials and Methods In this institutional review board-approved HIPAA-compliant retr

185 Materials and Methods For this institutional review board-approved HIPAA-compliant retr

186 This institutional review board-approved HIPAA-compliant retr

187 Materials and Methods For this institutional review board-approved HIPAA-compliant seco

188 terials and Methods This was a retrospective institutional review board-approved HIPAA-compliant stud

189 agnosed HL (n = 19) and NHL (n = 2) onto the Institutional Review Board-approved investigation of (11

190 agnosed HL (n = 19) and NHL (n = 2) onto the Institutional Review Board-approved investigation of (11

191 erials and Methods For this HIPAA-compliant, institutional review board-approved prospective blinded

192 ce of distant metastases were enrolled in an institutional review board-approved prospective clinical

193 ce of distant metastases were enrolled in an Institutional Review Board-approved prospective clinical

194 Materials and Methods An institutional review board-approved prospective database

195 aterials and Methods In this HIPAA-compliant institutional review board-approved prospective study in

196 Materials and Methods This was an institutional review board-approved prospective study in

197 Materials and Methods In this institutional review board-approved prospective study, 2

198 In this HIPAA-compliant, institutional review board-approved prospective study, 8

199 rials and Methods By using a HIPAA-compliant institutional review board-approved protocol where infor

200 /pheochromocytoma (MP) were treated using an institutional review board-approved protocol.

201 terials and Methods In this HIPAA-compliant, institutional review board-approved retrospective cohort

202 als and Methods Analysis was conducted on an institutional review board-approved retrospective data s

203 Materials and Methods An institutional review board-approved retrospective review

204 This study consisted of a HIPAA-compliant institutional review board-approved retrospective review

205 Materials and Methods In this institutional review board-approved retrospective review

206 Materials and Methods This institutional review board-approved retrospective study

207 ortability and Accountability Act-compliant, Institutional Review Board-approved retrospective study

208 Materials and Methods This HIPAA-compliant, institutional review board-approved retrospective study

209 Materials and Methods This HIPAA-compliant, institutional review board-approved retrospective study

210 Materials and Methods This HIPAA-compliant institutional review board-approved retrospective study

211 Materials and Methods This was an institutional review board-approved retrospective study,

212 In this institutional review board-approved retrospective study,

213 Materials and Methods This institutional review board-approved retrospective study,

214 l, clinical, and genetic findings as part of institutional review board-approved studies at Children'

215 from November 2010 to October 2012 for this institutional review board-approved study after they pro

216 icipate in this prospective HIPAA-compliant, institutional review board-approved study between April

217 This institutional review board-approved study from June 2007

218 Materials and Methods This institutional review board-approved study included 125 w

219 Materials and Methods This retrospective institutional review board-approved study included 24 pa

220 Materials and Methods This HIPAA-compliant, institutional review board-approved study measured the p

221 Materials and Methods This retrospective institutional review board-approved study received a wai

222 d Methods This retrospective HIPAA-compliant institutional review board-approved study was exempt fro

223 and Methods Written informed consent in this institutional review board-approved study was obtained f

224 A prospective, HIPAA-compliant, institutional review board-approved study was performed

225 Materials and Methods This HIPAA-compliant, institutional review board-approved study was performed

226 Materials and Methods In this retrospective, institutional review board-approved study, 120 patients

227 hods In this retrospective, HIPAA-compliant, institutional review board-approved study, 136 consecuti

228 ongitudinal, single-center, HIPAA-compliant, institutional review board-approved study, 157 patients

229 Materials and Methods In this institutional review board-approved study, 20 patients w

230 Materials and Methods In this retrospective, institutional review board-approved study, 33 patients w

231 Materials and Methods In this retrospective, institutional review board-approved study, 41 pediatric

232 Materials and Methods In this institutional review board-approved study, a public NSCL

233 terials and Methods In this HIPAA-compliant, institutional review board-approved study, all patients

234 Materials and Methods In this institutional review board-approved study, all unenhance

235 rials and Methods This was a HIPAA-compliant institutional review board-approved study, with informed

236 Materials and Methods In this institutional review board-approved study, with the writ

237 d patients provided informed consent in this institutional review board-approved study.

238 l patients provided informed consent in this institutional review board-approved study.

239 at 6 months and maintained in a prospective institutional review board-approved study.

240 ctive single-institution HIPAA-compliant and institutional review board-approved study.

241 astases were included in this retrospective, institutional review board-approved study.

242 ng with concomitant CT were enrolled in this institutional review board-approved study.

243 informed consent prior to inclusion in this institutional review board-approved study.

244 ening were compared in this HIPAA-compliant, institutional review board-approved study.

245 The study was HIPAA-compliant and institutional review board-approved with informed consen

246 This study was institutional review board-approved with waivers of info

247 ing from October 2011 to September 2012 with institutional review board-approved, HIPAA-compliant pro

248 Materials and Methods In this binational, institutional review board-approved, HIPAA-compliant pro

249 This institutional review board-approved, HIPAA-compliant pro

250 Materials and Methods This institutional review board-approved, HIPAA-compliant ret

251 tudy was a multireader, multi-institutional, institutional review board-approved, HIPAA-compliant ret

252 Materials and Methods This retrospective institutional review board-approved, HIPAA-compliant rev

253 erials and Methods This was a retrospective, institutional review board-approved, HIPAA-compliant stu

254 Materials and Methods In this institutional review board-approved, HIPAA-compliant stu

255 In this institutional review board-approved, HIPAA-compliant stu

256 Materials and Methods For this institutional review board-approved, HIPAA-compliant stu

257 Materials and Methods This institutional review board-approved, HIPAA-compliant stu

258 In an institutional review board-approved, HIPAA-compliant, pr

259 Materials and Methods This institutional review board-approved, HIPAA-compliant, re

260 Materials and Methods This institutional review board-approved, HIPAA-compliant, re

261 In this institutional review board-approved, informed consent-wa

262 Materials and Methods This was an institutional review board-approved, prospectively condu

263 This is an Institutional Review Board-approved, retrospective study

264 Materials and Methods SIESTA was an institutional review board-approved, single-center, pros

265 This retrospective HIPAA-compliant study was institutional review board-approved.

266 The institutional review board at each site approved the tri

267 Materials and Methods The institutional review board exempted this HIPAA-compliant

268 An institutional review board exemption and a waiver for in

269 Institutional review board exemptions were granted prior

270 s approval was obtained from the centralized institutional review board for this prospective single-a

271 This retrospective study was approved by the institutional review board; informed consent was obtaine

272 ve cross-sectional study was approved by the institutional review board; informed consent was obtaine

273 nd Methods This research was approved by the institutional review board (IRB) and was HIPAA compliant

274 ses/practices, protocol design, choice of an institutional review board (IRB), and trial outcomes.

275 essive disorder (TRD) who participated in an Institutional Review Board (IRB)-approved randomised dou

276 andards in the ethical review of research by institutional review boards (IRBs) due to the rush to en

277 The institutional review board of Beth Israel Deaconess Medi

278 tronic health records review approved by the institutional review board of the University Health Netw

279 ls and Methods The study was approved by the Institutional Review Board of the University Medical Cen

280 iant retrospective study was approved by the institutional review board of the University of Wisconsi

281 This retrospective study was approved by the institutional review board of three institutions.

282 Materials and Methods The institutional review boards of all participating centers

283 Materials and Methods The institutional review boards of each center approved this

284 Materials and Methods The institutional review boards of the four participating ce

285 HIPAA-compliant protocol was approved by the institutional review boards of the participating centers

286 This phantom-based study was exempt from institutional review board oversight.

287 aphy (CT) colonography Materials and Methods Institutional review board permission was obtained to us

288 ns from OLT patients were collected under an institutional review board protocol 2 hours after portal

289 xempt from review by the Columbia University Institutional Review Board, Protocol ID# AAAO3003.

290 The institutional review board provided a waiver of informed

291 lth Canada and was compliant with the HIPAA (Institutional Review Board Reg. #00000940).

292 priate ICU-based research, investigators and Institutional Review Boards should consider a deferred c

293 iant retrospective study was approved by the institutional review board; the requirement to obtain in

294 The institutional review board waived the need for consent.

295 The institutional review board waived the requirement for in

296 study that were exempted from review by the institutional review board, which consisted of 1007 post

297 This retrospective study was approved by the institutional review board, which waived the requirement

298 lity Act-compliant study was approved by our institutional review board with a waiver of informed con

299 This retrospective study was approved by the institutional review board with patient informed consent

300 rospective multicenter study was approved by institutional review boards with written informed consen